To achieve this, we optimized the well-known peptide tripeptide-1 (GHK) by separately grafting the integrin v3-binding motif RGD and the chondroitin sulfate (CS)-binding motif sOtx2 onto it, forming two chimeric targeting peptides, RGD-GHK and sOtx2-GHK
Diabetes Obes Metab 22(6):938946
No regulatory authority Health Canada, the FDA, the EMA, the TGA, or any equivalent has cleared BPC-157 for therapeutic use in humans or animals
CTAD marks the perfect moment to highlight why vascular phenotyping is no longer optionalbut a critical component of designing, powering, and interpreting the next generation of Alzheimers trials.
Some patients, for example those with weight-related health conditions or of certain ethnic minority backgrounds, can use them with a BMI of at least 27